diphenyldiselenide has been researched along with butylated hydroxytoluene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, FAR; Braga, AL; Canto, RFS; Rafique, J; Saba, S | 1 |
| Begnini, KR; Collares, T; da Rosa, RM; da Silva, FD; Dornelles, L; Piccoli, BC; Rocha, JBT; Rodrigues, OED; Seixas, FK; Sonego, MS | 1 |
| Collares, T; da Silva, FD; Dornelles, L; Dos Santos, ACF; Garcia, FD; Leitemberger, A; Nogara, PA; Oliveira, CS; Piccoli, BC; Rocha, JBT; Rodrigues, OED; Schachtschneider, KM; Seixas, FK; Sonego, MS | 1 |
3 other study(ies) available for diphenyldiselenide and butylated hydroxytoluene
| Article | Year |
|---|---|
Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Esters; Humans; Molecular Structure; Organoselenium Compounds; Pyrimidinones; Structure-Activity Relationship | 2016 |
Synthesis, antioxidant and antitumoral activities of 5'-arylchalcogeno-3-aminothymidine (ACAT) derivatives.
Topics: | 2017 |
Synthesis and biological evaluation of new antioxidant and antiproliferative chalcogenobiotin derivatives for bladder carcinoma treatment.
Topics: Antineoplastic Agents; Antioxidants; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Chalcogens; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lipid Peroxidation; Molecular Structure; Picrates; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neoplasms | 2020 |